Intubation and Tracheal Suctioning for Meconium Aspiration
No Results
No Results
processing….
Meconium is a viscous green-black substance that consists of denuded intestinal epithelial cells, ingested lanugo hair, mucus, digestive enzymes, bile acids, and water. The term meconium is derived from the Greek word mekonion, which means poppy juice or opium, presumably either because of its tarry appearance or because of Aristotle’s belief that it induced sleep in the fetus.
Meconium constitutes the first stool of a newborn infant. The passage of meconium typically occurs within 48 hours after birth; however, it can occur in utero. Postterm fetus may pass the meconium physiologically. Intrauterine meconium passage has been linked to fetal hypoxia and is associated with fetal acidosis, abnormal fetal heart tracings, and low Apgar scores. [1]
In preterm pregnancies, intrauterine meconium passage has been associated with fetomaternal stress and infection. [2] In term and postterm infants without fetal distress, intrauterine meconium passage may result from normal gastrointestinal (GI) maturation or from vagal stimulation caused by head or cord compression. [3] Meconium staining of the amniotic fluid occurs in approximately 13% of live births; this percentage increases with increasing gestational age at delivery. [3]
Meconium aspiration syndrome (MAS) occurs when meconium-stained amniotic fluid (MSAF) is aspirated into the lungs of an infant before, during, or immediately after birth (see the image below). Intrauterine gasping, resulting in aspiration of meconium, has been demonstrated in animal models exposed to hypoxia. [4, 5, 6] MAS occurs in approximately 5% of infants born through MSAF. [3] Even with modern neonatal intensive care, mortality from MAS remains high, in the range of 3-5%. [1, 7]
Many perinatal risk factors have been associated with meconium aspiration, including placental insufficiency, maternal hypertension, maternal diabetes mellitus, preeclampsia, oligohydramnios, and maternal tobacco use. [3, 8, 9] Perhaps the most significant risk factor, however, is postterm delivery. In a prospective clinical study, a decrease in the incidence of MAS from 5.8% to 1.5% over an 8-year period was attributed to a reduction in births at more than 41 weeks’ gestation. [10]
MAS occurs along a continuum from mild to severe. [11] Mild MAS is seen in infants born through MSAF who have mild respiratory symptoms; it probably reflects mild parenchymal irritation from aspirated meconium. Moderate MAS presents with more pronounced pulmonary symptoms, including moderately high oxygen requirements and a possible need for mechanical ventilation; it may reflect a more significant meconium load or the aspiration of thicker meconium into the lungs. [11]
Infants with severe MAS require mechanical ventilation with high settings and may need alternative therapies, such as inhaled nitric oxide (NO) and, possibly, extracorporeal membrane oxygenation (ECMO). [12] These cases probably represent a combination of meconium aspiration and persistent pulmonary hypertension of the newborn (PPHN). PPHN in these cases is thought to arise from chronic fetal compromise (hypoxia) with resultant pulmonary vascular remodeling.
There is evidence to suggest that chronic in utero hypoxia with resultant PPHN, rather than the aspiration of meconium per se, may be the primary pathologic problem in newborn infants diagnosed with severe MAS. [13, 14]
See the list below:
This new recommendation to no longer routinely suction nonvigorous infants arose from an emphasis on prevention of harm (ie, delays in providing bag-mask ventilation and potential consequences of unnecessary interventions) instead of the unknown benefit of the interventions of routine tracheal intubation and suctioning. [15]
Best practices
Several procedures have been used in the past to prevent MAS; none are supported by strong evidence of proven benefit.
Several other preventive measures that were commonly used in the past to prevent MAS, including amnioinfusion and intrapartum oronasopharyngeal suctioning, have now been largely abandoned as a result of findings from randomized, controlled trials.
Amnioinfusion involves the infusion of isotonic fluid (either normal saline or lactated Ringer solution) into the amniotic cavity via a transcervical intrauterine pressure catheter in an attempt to dilute the MSAF. The results of previous trials using amnioinfusion to prevent MAS have been mixed. However, given the heterogeneity of the studies and the small number of patients in each study, results must be interpreted with caution. [1]
A 2002 Cochrane review concluded that amnioinfusion was effective in reducing the incidence of MAS, especially in centers where perinatal surveillance was limited. [16] ; however, a 2010 update of this study found that substantive improvements in perinatal outcome were restricted to settings where facilities for perinatal surveillance are limited. [17] In a multinational, multicenter, randomized controlled trial involving 1998 women with thick MSAF, amnioinfusion had no significant effect on the incidence of MAS or death. [18]
These findings and the supposition that a large number of infants born through MSAF will have aspirated meconium before amnioinfusion can be performed prompted an ACOG opinion stating that “routine prophylactic amnioinfusion for the dilution of meconium-stained amniotic fluid should be done only in the setting of additional clinical trials.” [19] In this same statement, however, the ACOG noted that “amnioinfusion remains a reasonable approach in the treatment of repetitive variable decelerations, regardless of amniotic fluid meconium status.” [19]
In a randomized controlled trial involving 2514 full-term women with MSAF, Vain et al did not find intrapartum suctioning with a suction catheter to have a beneficial effect on need for endotracheal intubation, incidence of MAS, need for mechanical ventilation, and neonatal mortality. [20] The ACOG now recommends that “infants with MSAF should no longer receive intrapartum suctioning. [21]
Because meconium aspiration can occur before delivery as a consequence of chronic asphyxia and infection, perhaps the most important strategy for preventing MAS is good prenatal care, including the detection and prevention of fetal hypoxemia and the avoidance of postterm deliveries.
The equipment required for the management of meconium aspiration includes the following:
Laryngoscope with blade (size 1 for a term infant)
Uncuffed endotracheal tube (size 3.5-4.0 for a term infant)
DeLee suction catheter (12-14 French)
Meconium aspirator
Suction tubing
Medical suction device set to a continuous pressure of –80 to –120 mm Hg
Anesthesia is not required for emergency intubation and tracheal suctioning of infants born through meconium-stained amniotic fluid (MSAF).
Resuscitation must not be delayed just for intubation, however if airway is obstructed then endotracheal intubation and suctioning is required to have successful resuscitation. For intubation and tracheal suctioning, the infant should be placed on a flat surface, ideally under a radiant warmer. The head should be in midline position, with the neck slightly extended into the so-called sniffing position (see the image below). Placing a roll of towels under the infant’s shoulders may help maintain slight neck extension. Do not flex or hyperextend the neck; this raises the glottis above the line of sight and makes intubation more difficult. Caution should be exercised to limit the amount of time required for endotracheal intubation as infant is not being ventilated during that time and being delayed in receiving effective ventilation.
Hold the laryngoscope in the left hand, and stabilize the infant’s head with the right hand. Introduce the laryngoscope blade into the right side of the mouth, and sweep the tongue to the left with the laryngoscope blade. To make introduction of the laryngoscope blade easier, try using the right index finger to open the newborn’s mouth. Advance the laryngoscope blade until the tip is positioned on top of the epiglottis or immediately anterior to the epiglottis in the vallecula (see the image below).
Gently lift the laryngoscope blade upward to elevate the epiglottis and tongue to reveal the vocal cords (see the image below). Do not “rock back” with the laryngoscope blade; doing so may damage the alveolar ridge. Identify the vocal cords, and attempt to verify the presence of meconium below the level of the cords. If meconium is present, the posterior pharynx may have to be suctioned with a DeLee suction catheter to improve visualization of the cords.
Maintain direct visualization of the vocal cords as an assistant places the endotracheal tube into your right hand. Advance the endotracheal tube through open vocal cords until the vocal cord guide on the endotracheal tube is at the level of the cords (see the image below). If the vocal cords are approximated, wait for them to open. Do not force the endotracheal tube through closed vocal cords; doing so can damage the cords.
Stabilize the endotracheal tube in position by using an index finger to hold the tube against the hard palate. While holding the endotracheal tube in place, remove the laryngoscope blade. Ideally, the entire process of tracheal intubation should take less than 20 seconds. [22]
Attach a meconium aspirator, connected to a medical suction device supplying a continuous pressure of –80 to –120 mm Hg, to the endotracheal tube. Occlude the suction-control port on the meconium aspirator to apply suction (see the image below).
While applying suction, withdraw the endotracheal tube over a period of 3-5 seconds. If a substantial amount of meconium is returned by suction, intubation and suction should be repeated quickly or the newborn’s heart rate falls below 100 beats/min. If the heart rate is falling and infant is limp, endotracheal tube should be removed if it is significantly stained with meconium otherwise PPV should be provided through that endotracheal tube and rest of the resuscitation steps as per NRP.
Complications of intubation and tracheal suctioning include the following:
Trauma to lips, alveolar ridge, and tongue
Laryngospasm
Bronchospasm
Laryngeal trauma
Vocal cord injury or avulsion
Fractures and dislocation of arytenoids
Airway perforation
Esophageal intubation
Bronchial intubation
Bradycardia
Hypotension
Regurgitation of gastric contents
Velaphi S, Vidyasagar D. Intrapartum and postdelivery management of infants born to mothers with meconium-stained amniotic fluid: evidence-based recommendations. Clin Perinatol. 2006 Mar. 33(1):29-42, v-vi. [Medline].
Ahanya SN, Lakshmanan J, Morgan BL, Ross MG. Meconium passage in utero: mechanisms, consequences, and management. Obstet Gynecol Surv. 2005 Jan. 60(1):45-56; quiz 73-4. [Medline].
Walsh MC, Fanaroff JM. Meconium stained fluid: approach to the mother and the baby. Clin Perinatol. 2007 Dec. 34(4):653-65, viii. [Medline].
Block MF, Kallenberger DA, Kern JD, Nepveux RD. In utero meconium aspiration by the baboon fetus. Obstet Gynecol. 1981 Jan. 57(1):37-40. [Medline].
Adams FH, Desilets DT, Towers B. Control of flow of fetal lung fluid at the laryngeal outlet. Respir Physiol. 1967 May. 2(3):302-9. [Medline].
Dawes GS, Fox HE, Leduc BM, Liggins GC, Richards RT. Respiratory movements and rapid eye movement sleep in the foetal lamb. J Physiol. 1972 Jan. 220(1):119-43. [Medline].
Wiswell TE. Advances in the treatment of the meconium aspiration syndrome. Acta Paediatr Suppl. 2001 Mar. 90(436):28-30. [Medline].
Spain JE, Tuuli MG, Macones GA, Roehl KA, Odibo AO, Cahill AG. Risk factors for serious morbidity in term nonanomalous neonates. Am J Obstet Gynecol. 2015 Jun. 212 (6):799.e1-7. [Medline].
Frey HA, Tuuli MG, Shanks AL, Macones GA, Cahill AG. Interpreting category II fetal heart rate tracings: does meconium matter?. Am J Obstet Gynecol. 2014 Dec. 211 (6):644.e1-8. [Medline].
Yoder BA, Kirsch EA, Barth WH, Gordon MC. Changing obstetric practices associated with decreasing incidence of meconium aspiration syndrome. Obstet Gynecol. 2002 May. 99(5 Pt 1):731-9. [Medline].
Wiswell TE, Bent RC. Meconium staining and the meconium aspiration syndrome. Unresolved issues. Pediatr Clin North Am. 1993 Oct. 40(5):955-81. [Medline].
Vain NE, Szyld EG, Prudent LM, Aguilar AM. What (not) to do at and after delivery? Prevention and management of meconium aspiration syndrome. Early Hum Dev. 2009 Oct. 85(10):621-6. [Medline].
Blackwell SC, Moldenhauer J, Hassan SS, Redman ME, Refuerzo JS, Berry SM. Meconium aspiration syndrome in term neonates with normal acid-base status at delivery: is it different?. Am J Obstet Gynecol. 2001 Jun. 184(7):1422-5; discussion 1425-6. [Medline].
Ghidini A, Spong CY. Severe meconium aspiration syndrome is not caused by aspiration of meconium. Am J Obstet Gynecol. 2001 Oct. 185(4):931-8. [Medline].
Committee on Obstetric Practice. Committee Opinion No 689: Delivery of a Newborn With Meconium-Stained Amniotic Fluid. Obstet Gynecol. 2017 Mar. 129 (3):e33-e34. [Medline].
Hofmeyr GJ. Amnioinfusion for meconium-stained liquor in labour. Cochrane Database Syst Rev. 2002. CD000014. [Medline].
Hofmeyr GJ, Xu H. Amnioinfusion for meconium-stained liquor in labour. Cochrane Database Syst Rev. 2010 Jan 20. CD000014. [Medline].
Fraser WD, Hofmeyr J, Lede R, et al. Amnioinfusion for the prevention of the meconium aspiration syndrome. N Engl J Med. 2005 Sep 1. 353(9):909-17. [Medline].
ACOG Committee Opinion Number 346, October 2006: amnioninfusion does not prevent meconium aspiration syndrome. Obstet Gynecol. 2006 Oct. 108(4):1053. [Medline].
Vain NE, Szyld EG, Prudent LM, Wiswell TE, Aguilar AM, Vivas NI. Oropharyngeal and nasopharyngeal suctioning of meconium-stained neonates before delivery of their shoulders: multicentre, randomised controlled trial. Lancet. 2004 Aug 14-20. 364(9434):597-602. [Medline].
ACOG Committee on Obstetric Practice. ACOG Committee Opinion No. 379: Management of delivery of a newborn with meconium-stained amniotic fluid. Obstet Gynecol. 2007 Sep. 110(3):739. [Medline].
Kattwinkle J. Textbook of Neonatal Resuscitation. 5th ed. Chicago: American Academy of Pediatrics; 2005.
Wiswell TE, Gannon CM, Jacob J, Goldsmith L, Szyld E, Weiss K. Delivery room management of the apparently vigorous meconium-stained neonate: results of the multicenter, international collaborative trial. Pediatrics. 2000 Jan. 105(1 Pt 1):1-7. [Medline].
Halliday HL. Endotracheal intubation at birth for preventing morbidity and mortality in vigorous, meconium-stained infants born at term. Cochrane Database Syst Rev. 2001. CD000500. [Medline].
Gabbe SR, Niebyl JR, Simpson JL. Obstetrics: Normal and Problem Pregnancies. 5th ed. Philadelphia: Elsevier; 2007.
Taylor L Sawyer, DO, MEd, FAAP, FACOP Associate Professor of Pediatrics, University of Washington School of Medicine; Director, Neonatal-Perinatal Fellowship, Seattle Children’s Hospital
Taylor L Sawyer, DO, MEd, FAAP, FACOP is a member of the following medical societies: Academic Pediatric Association, American Academy of Pediatrics, American College of Osteopathic Pediatricians, American Medical Association, American Osteopathic Association, Association of American Medical Colleges, International Pediatric Simulation Society, Society for Simulation in Healthcare
Disclosure: Nothing to disclose.
George Graham, MD Assistant Professor of Maternal-Fetal Medicine, University of Hawaii, John A Burns School of Medicine
George Graham, MD is a member of the following medical societies: American College of Obstetricians and Gynecologists, American Institute of Ultrasound in Medicine, Society for Maternal-Fetal Medicine
Disclosure: Nothing to disclose.
Dharmendra J Nimavat, MD, FAAP Associate Professor of Clinical Pediatrics, Department of Pediatrics, Division of Neonatology, Southern Illinois University School of Medicine; Staff Neonatologist, Clinical Director, NICU Regional Perinatal Center, HSHS St John’s Children’s Hospital
Dharmendra J Nimavat, MD, FAAP is a member of the following medical societies: American Academy of Pediatrics, American Association of Physicians of Indian Origin
Disclosure: Nothing to disclose.
Ted Rosenkrantz, MD Professor, Departments of Pediatrics and Obstetrics/Gynecology, Division of Neonatal-Perinatal Medicine, University of Connecticut School of Medicine
Ted Rosenkrantz, MD is a member of the following medical societies: American Academy of Pediatrics, American Pediatric Society, Eastern Society for Pediatric Research, American Medical Association, Connecticut State Medical Society, Society for Pediatric Research
Disclosure: Nothing to disclose.
Mark W Thompson, MD Chief of Pediatrics, Pediatric Consultant to Surgeon General, Tripler Army Medical Center
Mark W Thompson, MD is a member of the following medical societies: American Academy of Pediatrics
Disclosure: Nothing to disclose.
Mary L Windle, PharmD Adjunct Associate Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference
Disclosure: Nothing to disclose.
Acknowledgments
The views expressed in this manuscript are those of the author(s) and do not reflect the official policy or position of the Department of the Army, Department of Defense, or the US Government.
Intubation and Tracheal Suctioning for Meconium Aspiration
Research & References of Intubation and Tracheal Suctioning for Meconium Aspiration|A&C Accounting And Tax Services
Source
0 Comments